An MND/ALS phenotype associated with C9orf72 repeat expansion: Abundant p62‐positive, TDP‐43‐negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neuropathology (Kyoto. 1993)

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1440-1789.2011.01286.xPMID 22181065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

  2011influential reference
• Characterising the RNA targets and position-dependent splicing regulation by TDP-43; implications for neurodegenerative diseases

  2011cited by this paper
• Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP‐43 proteinopathies but are only rarely additionally immunopositive for phosphorylation‐dependent TDP‐43

  2011influential reference
• Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p

  2011cited by this paper
• Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

  2011cited by this paper
• p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS

  2011cited by this paper
• Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders

  2011influential reference
• Mutations of optineurin in amyotrophic lateral sclerosis

  2010influential reference
• Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.

  2010cited by this paper
• Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study

  2010cited by this paper
• Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family

  2010cited by this paper
• Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6

  2009influential reference
• TDP‐43 is consistently co‐localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations

  2009cited by this paper
• Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

  2009cited by this paper
• RNA‐mediated neurodegeneration in repeat expansion disorders

  2009cited by this paper
• Accumulation of TDP-43 and α-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation

  2009cited by this paper
• Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions Visualized With Ubiquitin-Binding Protein p62 Immunohistochemistry

  2008cited by this paper
• Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations

  2008cited by this paper
• Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

  2008cited by this paper
• Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease.

  2008cited by this paper
• TDP‐43 mutation in familial amyotrophic lateral sclerosis

  2008cited by this paper
• TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.

  2008cited by this paper
• TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

  2008cited by this paper
• TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.

  2007cited by this paper
• Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

  2007cited by this paper
• p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by Autophagy*

  2007cited by this paper
• ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis

  2006cited by this paper
• Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3.

  2006cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006influential reference
• Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

  2006cited by this paper
• A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis.

  2004cited by this paper
• Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders

  2004cited by this paper
• p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases.

  2002cited by this paper
• Mutations in all five exons of SOD‐1 may cause ALS

  1998cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• Two rapid and simple methods used for the removal of resins from 1.0 μm thick epoxy sections

  1978cited by this paper
• Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells.

  1967cited by this paper
• THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY

  1963cited by this paper
• Histological Techniques for Electron Microscopy

  1961cited by this paper
• Embedding in epoxy resins for ultrathin sectioning in electron microscopy.

  1960cited by this paper

• Sensory Dysfunction in ALS and Other Motor Neuron Diseases: Clinical Relevance, Histopathology, Neurophysiology, and Insights from Neuroimaging

  2025cites this paper
• The cerebellum in frontotemporal dementia: from neglected bystander to potential neuromodulatory target. A narrative review.

  2025cites this paper
• Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion

  2024cites this paper
• C9orf72-associated dipeptide protein repeats form A11-positive oligomers in amyotrophic lateral sclerosis and frontotemporal dementia

  2024cites this paper
• DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD.

  2024cites this paper
• Targeting mitochondrial Ca2+ uptake for the treatment of amyotrophic lateral sclerosis

  2023cites this paper
• Thalamic pathology in frontotemporal dementia: Predilection for specific nuclei, phenotype‐specific signatures, clinical correlates, and practical relevance

  2023cites this paper
• Distinct neuroinflammatory signatures exist across genetic and sporadic ALS cohorts

  2023cites this paper
• Distinct neuroinflammatory signatures exist across genetic and sporadic amyotrophic lateral sclerosis cohorts

  2023cites this paper
• The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

  2022cites this paper
• Focal thalamus pathology in frontotemporal dementia: Phenotype-associated thalamic profiles.

  2022cites this paper
• An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD

  2022cites this paper
• Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72‐ALS

  2022cites this paper
• How can we define the presymptomatic C9orf72 disease in 2022? An overview on the current definitions of preclinical and prodromal phases.

  2022cites this paper
• Random forest modelling of neuropathological features identifies microglial activation as an accurate pathological classifier of C9orf72-related amyotrophic lateral sclerosis

  2021cites this paper
• The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development

  2021cites this paper
• Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond.

  2021cites this paper
• Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD

  2021cites this paper
• Nanoscopic investigation of C9orf72 poly-GA oligomers on nuclear membrane disruption by a photoinducible platform

  2021cites this paper
• Autophagy and ALS: mechanistic insights and therapeutic implications

  2021cites this paper
• Looking beneath the surface: the importance of subcortical structures in frontotemporal dementia

  2021cites this paper
• Elucidating the Role of Cerebellar Synaptic Dysfunction in C9orf72-ALS/FTD — a Systematic Review and Meta-Analysis

  2021cites this paper
• Genetic architecture of motor neuron diseases.

  2021cites this paper
• Aberrant Stress Granule Dynamics and Aggrephagy in ALS Pathogenesis

  2021cites this paper
• Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia.

  2020cites this paper
• Genetic forms of frontotemporal lobar degeneration: Current diagnostic approach and new directions in therapeutic strategies.

  2020cites this paper
• Implications of Selective Autophagy Dysfunction for ALS Pathology

  2020cites this paper
• Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  2020cites this paper
• Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels

  2019cites this paper
• Nuclear RNA foci from C9ORF72 expansion mutation form paraspeckle-like bodies

  2019cites this paper
• TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis/frontotemporal lobar degeneration

  2019cites this paper
• Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion

  2019cites this paper
• Deregulated miR-29b-3p Correlates with Tissue-Specific Activation of Intrinsic Apoptosis in An Animal Model of Amyotrophic Lateral Sclerosis

  2019cites this paper
• Autophagy as a common pathway in amyotrophic lateral sclerosis.

  2019cites this paper
• PhD IN BIOMEDICAL SCIENCES DEPARTMENT OF BRAIN AND BEHAVIORAL SCIENCES UNIT OF NEUROPHYSIOLOGY Regulatory role of TDP-43 on R-loop formation in Amyotrophic Lateral Sclerosis (ALS)

  2019cites this paper
• The Genetics of C9orf72 Expansions.

  2018cites this paper
• Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementia

  2018cites this paper
• Tremor in motor neuron disease may be central rather than peripheral in origin

  2018cites this paper
• p62/SQSTM1 – steering the cell through health and disease

  2018influential citation
• Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration.

  2017cites this paper
• Monocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP‐43 subcellular distribution

  2017cites this paper
• Biological Spectrum of Amyotrophic Lateral Sclerosis Prions.

  2017cites this paper
• Potential multisystem degeneration in Asidan patients.

  2017cites this paper
• Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity

  2017cites this paper
• C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking

  2017cites this paper
• The Neuroprotective Marine Compound Psammaplysene A Binds the RNA-Binding Protein HNRNPK

  2017cites this paper
• Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS).

  2017cites this paper
• Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72

  2017cites this paper
• Structural and functional brain signatures of C9orf72 in motor neuron disease.

  2017cites this paper
• Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion

  2017influential citation
• The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD

  2017cites this paper
• Nuclear trafficking in amyotrophic lateral sclerosis and frontotemporal lobar degeneration

  2017cites this paper
• hexanucleotide expansions are associated with altered ER calcium homeostasis and stress granule formation in iPSC-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal dementia

  2016cites this paper
• C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell‐Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  2016cites this paper
• The Use of Stem Cells to Model Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: From Basic Research to Regenerative Medicine

  2016cites this paper
• C9ORF72 repeat expansion is not detected in sporadic ataxia patients in mainland China.

  2016cites this paper
• Developing and characterizing cellular models for neurodegenerative diseases.

  2016cites this paper
• Investigation of the cell- and non-cell autonomous impact of the C9orf72 mutation on human induced pluripotent stem cell-derived astrocytes

  2016cites this paper
• Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion

  2016cites this paper
• Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: a systematic neuropathological review

  2016cites this paper
• Frontotemporal lobar dementia and amyotrophic lateral sclerosis associated with c9orf72 expansion.

  2015cites this paper
• Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions

  2015cites this paper
• C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis.

  2015cites this paper
• Characterization of DNA G-quadruplex species forming from C9ORF72 G4C2-expanded repeats associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

  2015cites this paper
• Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration

  2015cites this paper
• From nucleation to widespread propagation: A prion-like concept for ALS.

  2015cites this paper
• Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia

  2015cites this paper
• Modelling C9orf72-linked frontotemporal dementia and amyotrophic lateral sclerosis

  2015cites this paper
• RNA Dysfunction and RNA binding Proteins in the Syndrome of ALS / FTD

  2015cites this paper
• Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer’s disease

  2015cites this paper
• TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets

  2015cites this paper
• Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD.

  2015cites this paper
• Communication of diagnosis in amyotrophic lateral sclerosis: stratification of patients for the estimation of the individual needs

  2015cites this paper
• Update on Hippocampal Sclerosis

  2015cites this paper
• Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis.

  2015cites this paper
• Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers

  2015cites this paper
• Erratum to: TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets

  2015cites this paper
• Drosha Inclusions Are New Components of Dipeptide-Repeat Protein Aggregates in FTLD-TDP and ALS C9orf72 Expansion Cases

  2015cites this paper
• Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration

  2014cites this paper
• Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia

  2014cites this paper
• C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration

  2014cites this paper
• The neuropathology associated with repeat expansions in the C9ORF72 gene

  2014cites this paper
• C9ORF72‐ALS: P62‐ and ubiquitin‐aggregation pathology in skeletal muscle

  2014cites this paper
• Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

  2014cites this paper
• Amyotrophic Lateral Sclerosis: A Genetic Point of View.

  2014cites this paper
• C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking

  2014cites this paper
• Amyotrophic lateral sclerosis and frontotemporal lobar degeneration

  2014cites this paper
• Factores genéticos asociados a la degeneración lobar frontotemporal. Análisis de susceptibilidad genética y correlación fenotipo-genotipo

  2014influential citation
• An autopsy case of incipient Pick's disease: Immunohistochemical profile of early‐stage Pick body formation

  2014cites this paper
• How do C9ORF72 repeat expansions cause ALS and FTD: can we learn from other non-coding repeat expansion disorders?

  2014cites this paper
• Frontotemporal lobar degeneration with TDP‐43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation

  2013cites this paper
• Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum.

  2013cites this paper
• Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease

  2013cites this paper
• Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant

  2013cites this paper
• Multiparametric MRI study of ALS stratified for the C9orf72 genotype

  2013cites this paper
• Clinicopathological review of pallidonigroluysian atrophy

  2013cites this paper
• The clinical and pathological phenotypes of frontotemporal dementia with C9ORF72 mutations.

  2013cites this paper
• Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations

  2013cites this paper
• Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion

  2013cites this paper
• Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis

  2013cites this paper